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Background: Inflammatory response in the CNS mediated by microglia cells play an important role in host defense
and is implicated in the pathology of neurodegenerative diseases. We investigated the capacity of Entada africana
to protect microglia from inflammatory insults by exploring the effect of the CH2Cl2/MEOH 5% fraction (Ea5) on
pro-inflammatory cytokines mRNA expression. Finally, we studied the effect of Ea5 on the inhibition of p38 MAPK
Kinase. The results were compared to those obtained with Baicalin, a well reported anti-inflammatory flavonoid.
Methods: Barks from E. africana were harvested in 2010, in the west region of Cameroon. A crude extract was
prepared using CH2Cl2/MEOH 1:1 V/V. The crude extract obtained was further fractionated by flash chromatography.
A mouse microglia cell line (N9) was stimulated by LPS with or without different concentrations of Baicalin and Ea5.
The release of NO was evaluated using the Griess method. The expression of pro-inflammatory cytokines mRNA
(TNFα, IL-1β, IL-6) and iNOS/NO were measured by RT- PCR. The inhibition of p38 MAPK Kinase was assessed using
ELISA.
Results: We found that Ea5, as well as Baicalin inhibited LPS-induced NO production in a dose dependent manner.
Ea5 was most active in term of NO inhibition (87.07%), in comparison to Baicalin (70.85%). The expression of TNFα,
IL-1β, IL-6 and iNOS was strongly suppressed by Ea5 in microglia. Ea5 also inhibited the activity of p38MAPK Kinase,
up to 30% for the concentrations tested, whereas a prominent inhibition was obtained with Baicalin.
Conclusion: These results suggest that E. africana may contain promising compounds useful for the treatment of
diseases cause by over-activation of microglia such as Alzheimer disease and other neurological diseases.
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Inflammation has recently been implicated as a critical
mechanism responsible for the progression of neurodegen-
erative disorders [1]. Microglia, the resident macrophage-
like cells in the brain are reported to produce a barrage of
elements (IL-1,TNFα,NO, PGE2, superoxide) that are toxic
to neurons [2]. Microglia have a critical role in host defense
against invading microorganisms and their actions appear* Correspondence: pmoundipa@hotmail.com
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reproduction in any medium, provided the orto influence neuronal proliferation, as well as contribute to
the removal of dying neurons or cellular debris [3]. The ef-
fects of microglia on the central nervous system can be as-
cribed to the numerous substances that these cells can
synthesize and release in response to a variety of stimuli
(cytokines, pro-inflammatory substances, toxins, etc.) [4].
Moreover,microglia activation is associatedwith thepatho-
genesis and progression of diseases such asAlzheimer’s dis-
ease (AD), Parkinson’s’ disease, multiple sclerosis, and
traumatic brain injury [5].
Mitogen-activated protein kinases (MAPKinase) are
intracellular signaling kinases activated by phosphorylationLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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tors of p38 MAP kinase are considered as suitable targets
in the treatment of inflammatory diseases [7]. As a result of
these observations, many inhibitors of p38 MAPKinase are
more and more investigated for their anti-inflammatory
effects [8,9].
Therapeutic approaches focused on inhibition of the
microglia-mediated local inflammatory response in the
brain may offer new opportunities to treat neurological
diseases. Amongst them, Baicalin (BA) is a flavonoid
compound purified from the Chinese medicinal plant
Scutellaria baicalensis Georgi. Baicalin regulated Toll-like
receptor 2/4 after ischemic neuronal injury and the inflam-
matory reaction in neuron damage [10]. Baicalin improved
survival in a murine model of polymicrobial sepsis via sup-
pressing inflammatory response and lymphocyte apoptosis
[11]. Baicalin attenuated inflammation by inhibiting NF-
kappaB activation in cigarette smoke induced inflamma-
tory models [12]. Many in vitro studies showed that
Baicalin suppressed the increased generation of nitric
oxide (NO) and expression of inducible nitric oxide syn-
thase (iNOS) induced by LPS [13].
E. africana (Guill. & Perr, Family: Fabaceae) is used in
African traditional medicine for the treatment of many
diseases. The plant is used in Mali for the treatment of
Malaria [14]. Anti-inflammatory, hepatoprotective and
wound healing effects have also been demonstrated [15].
In Burkina Faso, the plant is used for the treatment of
diabetes, hypertension and diarrhea. In Cameroon, the
plant is used for the treatment of wound dressing, fever,
liver related diseases, wound healing, rheumatism,
cataract, fevers and dysentery. Studies on E. africana
concern antimicrobial, antiplasmodial and antioxidant
activities [16], fungistatic, fungicidal [17] and anti-
ulcerogenicactivities [18].
In a recent article published by our research group, we
showed that E. africana fraction CH2Cl2/MeOH 1.1 V/V
5% (Ea5) suppresses lipopolysaccharide-induced inflam-
mation in Raw 264.7 macrophages [19]. Here we investi-
gated the effect of Ea5 on NO production and the
expression of pro-inflammatory cytokines mRNA by
microglia in response to LPS. We also examined the ef-
fect of Ea5 and Baicalin on iNOS mRNA expression and
on p38 MAP Kinase inhibition.
Methods
Plant materials and solvent extraction
E. africana was harvested in 2010, in the West region of
Cameroon. The Voucher specimen was identified by
Dr Njayou Frederic Nico of the University of Yaoundé I,
Cameroon, and deposited at the National Herbarium,
Yaoundé, Cameroon (ID: 244366, Voucher number:
52661 YA). Dried E. africana barks were air dried, cut
into small pieces and ground. One Kg of the powder wasimmersed and extracted in methylene chloride/methanol
1/1 v/v at room temperature for 7 days. After the mix-
ture was filtered, the filtered cakes were extracted and
filtered three more times to increase the extraction yield.
The procedure was repeated until the solvent present a
clear color. The filtrate was concentrated under reduced
pressure, and the crude extract obtained was freeze-
dried, and stored at 4°C until used. The crude extract
was subjected to flash chromatography to obtain the Ea5
fraction (CH2Cl2/MeOH 5%).
Chemicals
Fetal bovine serum (FBS), antibiotics (streptomycin/peni-
cillin), and RPMI medium were purchased from Gibco
(Grand Island, NY, USA). Escherichia coli-LPS and
3-(4, 5- dimethylthiazol-2-yl) -2, 5- diphenyltetrazolium
bromide (MTT) were purchased from Sigma-Aldrich
(St. Louis, MO, USA). Baicalin (99%) was purchased from
Carbosynth Ltd. (Compton, Berkshire, UK). Mouse cyto-
kines primers (iNOS, TNFα, IL-6, and IL-1β) were sup-
plied by Santa Cruz Biotechnology (Santa Cruz, CA, USA).
In vitro cell culture
The microglia cell line N9 was used to determine the effects
of E. africana on inflammation in vitro. The cells were cul-
tured in RPMI medium (Life Technologies) containing peni-
cillin (100U/ml), and 10% fetal bovine serum. Cells were
cultured at 37°C in a humidified incubator at an atmosphere
of 5% CO2. N9 cells were grown in 12-well plates at a density
of approximately 1 × 105 cells per well. The plant compounds
were dissolved in dimethylsulfoxide (DMSO) and filtered
through 0.45micrometer cellulosemembranes.
MTT assay for measuring cell proliferation
The cytotoxic effect of Ea5 was evaluated by a MTT assay.
3-(4, 5- dimethylthiazol-2-yl) -2, 5- diphenyltetrazolium
bromide (MTT) is a pale yellow substrate that is reduced
by living cells to yield a dark blue formazan product. This
process requires active mitochondria, and only dead cells
do not reduce significant amounts of MTT. Cells were
seeded in 12-well plates (1 × 105 cells/well) and incubated
for 24 h. After this incubation period, cells were treated
with various concentrations of E. africana (0.01, 0.1, 1, 10,
and 100 μg/ml), Baicalin (5 μg/ml) and LPS (1 μg/ml) at
37°C in 5% CO2 for 24 h. After treatment, 100 μL of MTT
(5 mg/ml) dissolved in RPMI was added to each well,
followed by incubation for 3 h. The medium was aspi-
rated, and the formazan crystals were dissolved in 500 μL
of DMSO for 15 min. The optical density of each well was
measured at 540 nm in a microplate reader.
Determination of nitric oxide production
Production of NO was determined by measuring the ac-
cumulated level of nitrite, an indicator of NO in the
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different concentrations of plant material and Baicalin.
After pre-incubation of cells (1 ×105 cells) for 24 h,
Baicalin, or Ea5 (0.05, 0.5, 5, and 50 μg/ml) were added,
together with LPS (1 μg/ml). The cells were further in-
cubated at 37°C, 5% CO2 for 24 h. The quantity of nitrite
in the culture medium was measured as an indicator
of NO production. Amounts of nitrite, a stable meta-
bolite of NO, were measured using Griess reagent
(1% sulfanilamide and 0.1% naphthyl ethylene diamine
dihydrochloride in 2.5% phosphoric acid). Briefly, 50 μl
of cell culture medium was mixed with 100 μl of Griess
reagent. Subsequently, the mixture was incubated at
room temperature for 10 min and the absorbance at
570 nm was measured in a microplate reader. Fresh cul-
ture medium was used as a blank in every experiment.
The quantity of nitrite was determined from a sodium
nitrite standard curve.
RNA Extraction and Reverse Transcription-Polymerase
Chain Reaction (RT-PCR)
N9 cells were treated with Baicalin, Ea5 and LPS
(1 μg/ml) for 24 h. Total RNA from LPS-treated N9 cells
was prepared using the innuPREP RNA Mini kit
(QIAGEN GmbH, Hilden, Germany) according to the
manufacturer’s protocol. cDNA (1 μg/ml) was synthe-
sized from 1 μg of total RNA and was used to perform
RT-PCR. After initial denaturation for 2 min at 95°C,
thirty amplification cycles were performed for iNOS
(1 min of 95°C denaturation, 1 min of 60°C annealing,
and 1.5 min 72°C extension), TNF-α (1 min of 95°C
denaturation, 1 min of 55°C annealing, and 1 min 72°C
extension), IL-1β (1 min of 94°C denaturation, 1 min of
60°C annealing, and 1 min 72°C extension), IL-6 (1 min
of 94°C denaturation, 1 min of 60°C annealing, and
1 min 72°C extension) and β-actin (1 min of 94°C
denaturation, 1 min of 60°C annealing, and 1 min 72°C
extension). The primer sequences used for quantification
of iNOS, TNF α, IL-1 β, IL-6, β-actin and the PCR condi-
tions are described in the Table 1. PCR products were
separated by 1.5% agarose gel electrophoresis containing
10 mg/ml ethidium bromide, photographed using UVsolo
system (Whatman Biometra, Goettingen, Germany) and
densitometric analysis was performed with the software
BioDocAnalyze (Whatman Biometra). Results were cal-
culated as levels of target mRNAs relative to those of
β-actin.
p38 MAP Kinase inhibition assay
The inhibition of p38 MAP kinase was realized as de-
scribed by [20]. Briefly, 96-well plates were coated with
ATF-2, overnight, at 4°C. Blocking buffer was added at
room temperature and the plates were incubated for
30 min before the addition of the kinase reaction mixcontaining the enzyme, with or without test compounds.
The p38α reaction was carried out by using kinase
(12 ng per well), ATP (100 μM), for 45 min at 37°C. The
ATF-2 phosphorylation was detected with a specific
anti-phospho ATF-2 (Thr69/71) antibody (60 min at
37°C). After each incubation time, the plate was washed
three times with double distilled water. The optical
density was measured after the addition of the substrate
at 450 nm, by a plate reader. The p38 MAPK Kinase in-
hibitor SB203580 was used as a reference compound.
Statistical analysis
All experiments were reiterated at least three times in
triplicate. The results of multiple observations are
expressed as the mean ± SD. Statistical significance was
determined by one-way analysis of variance (ANOVA)
using Graph Pad Prism 5.0 for windows. For all statis-
tical analyses, significance levels were set at P < 0.05.
Results
Effect of Entada africana on the viability of N9 cells
Examination of the cytotoxicity of Ea5 on N9 cells by
MTT assay indicated that these compounds, even at
100 μg/ml, did not affect the viability of N9 cells
(Figure 1).
Ea5 Inhibition of LPS-induced NO production in N9
microglia
The effects of Ea5 on LPS-induced NO production
in N9 microglia were investigated by measuring the
accumulated nitrite, as estimated by the Griess reac-
tion in the culture medium. After treatment with
LPS (1 μg/ml) for 24 h, nitrite concentrations in the
medium increased remarkably by approximately 10
fold. When N9 microglia were treated with different
concentrations of the indicated compounds together
with LPS (1 μg/ml) for 24 h, a significant (P < 0.001)
Figure 1 Effect of E. africana and Baicalin on the viability of LPS-activated N9 cells. (A) N9 cells 1x105cells/ml were incubated with the
indicated concentrations of E. africana and Baicalin (5 μg/ml) in the presence of LPS 1 μg/ml for 24 h. The cell viability was then determined by
MTT assay as described in the Methods. (B): N9 cells incubated with DMSO for 24 h (C): N9 cells incubated with LPS (1 μg/ml) and E. africana
(50 μg/ml) for 24 h. (D): N9 cells incubated with LPS (1 μg/ml) and Baicalin (5 μg/ml) for 24 h.
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tion was detected in the presence Ea5 (Figure 2).Figure 2 Inhibition of LPS-induced production of Nitric Oxide
by E. africana. The extract was prepared according to the protocol
and added to cultured N9 cells together with LPS at 1 μg/ml. The
plant extract was applied at final concentrations ranging from 0.05
to 50 μg/ml. Baicalin was used at 5 μg/ml. Following 24 h
incubation, cell supernatant was collected and NO was quantified as
described in Methods. * P < 0.05, **P < 0.01 and ***P < 0.001
compared to LPS treated group. ≠ indicate no significant difference
between the control group and Ea50 treated group. Error bars
indicate standard deviation.Effects of Ea5 on pro-inflammatory cytokines and iNOS
mRNA expression
We next investigated whether Ea5 suppresses the pro-
duction of pro-inflammatory cytokines, such as IL-6,
IL-1β and TNFα in LPS-stimulated microglia cells. For
this study, N9 microglias were incubated with Ea5 and
Baicalin in the presence or absence of LPS for 24 h, and
the cytokines mRNA expressions were evaluated. As
shown in Figure 3A, B and C, 1 μg/ml LPS significantly
increased IL1-β, IL-6 and TNFα mRNA levels in cells of
the microglia cell line N9. E. africana significantly
inhibited IL-6 mRNA expression at 50 μg/ml (P < 0.001).
A significant inhibition of IL-1β was obtained with Ea5
at 0.5, 5 and 50 μg/ml (P < 0.001). The same effect was
observed with Baicalin. A minor but significant inhib-
ition of the mRNA expression of TNFα was obtained at
5 and 50 μg/ml (P < 0.05), whereas a significant inhib-
ition was obtained with Baicalin at the tested concentra-
tion (P < 0.01).
We carried out RT-PCR to investigate the question
whether inhibition of NO production was associated
with decreased levels of iNOS expression. As shown in
Figure 3D, 1 μg/ml LPS significantly increased iNOS
mRNA levels in these cells after 24 h treatment. Ea5 sig-
nificantly reduced the mRNA expression of iNOS at
Figure 3 Effect of E. africana fraction CH2Cl2/MeOH 5% on LPS-induced expression of proinflammatory cytokines and iNOS in
microglia. N9 cells were pre-treated with different concentrations of Ea5 (0.05, 0.5, 5 and 50 μg/ml) and or Baicalin (5 μg/ml), with or without
LPS for a stimulation period of 24 h. Total RNAs were isolated, and mRNA levels of IL1β, IL6 and TNFα were measured by RT-PCR. β-actin
expression was used as an internal control. (A). IL1β, (B). IL6 and (C). TNFα.* P < 0.05, **P < 0.01 and ***P < 0.001 compared to LPS treated group.
(D): E. africana fraction CH2Cl2/MeOH 5% and Baicalin reduced LPS-induced iNOS gene expression in macrophage cell line. N9 cells were
incubated without or with LPS 1 μg/ml together with the indicated amounts of the extract or Baicalin. After 24 hours iNOS mRNA was quantified
by qRT-PCR.* P < 0.05, **P < 0.01 and ***P < 0.001 compared to LPS treated group.
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served at 5 μg/ml and with Baicalin (P < 0.05).
Effect of Ea5 on p38 MAPK Kinase inhibition
MAPKs constitute a family of specific serine/threonine
kinases that phosphorylate target substrates, thereby
control important cellular functions such as gene ex-
pression [21]. Ea5 and Baicalin were tested for their abil-
ity to inhibit p38MAPK Kinase. This was evaluated by
using a p38α ELISA assay containing BSA (0.01%) in the
kinase buffer. In our experiment, the p38 MAPK inhibi-
tor SB203580 (IC50 = 0.048+/− 0.01 μM) was used as a
reference compound for the p38α kinase assay. Ea5
showed a moderate inhibitory effect on the enzyme over
the concentration range tested (0.1 to 100 μg/ml).
Baicalin inhibited the activity of p38 MAPK Kinase up
to 80% (Figure 4).Discussion
Inflammation plays an important role in the pathology
of neurodegenerative disorders in the brain [22]. In par-
ticular, neuroinflammation with prolonged activation of
microglia cells leads to an increased activation of these
cells and to increased production of proinflammatory
mediators and cytokines [23], contributing to neuronal
dysfunction and neuronal cell death. Therefore, inhibi-
tors of these inflammatory molecules have been consid-
ered as candidate anti-inflammatory drugs for alleviating
the progression of neurodegenerative diseases caused by
activation of microglia. The expression of iNOS and
the overproduction of NO are considered to play a sig-
nificant role in the pathogenesis of various neurodegen-
erative diseases. For instance, overproduction of NO by
microglia contributes to the complication of AD [24]
and Parkinson’s disease [25].
Figure 4 Effect of E. africana fraction CH2Cl2/MeOH 5% and
Baicalin on the inhibition of p38 MAPK Kinase activity. The
inhibitory potency of the fraction and Baicalin was evaluated by
using p38α ELISA assay containing BSA (0.01%) in the kinase buffer.
SB203580 was used as reference compound.
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E. africana fraction CH2Cl2/MeOH5%onNOproduction
aswell as on the expression of pro-inflammatory cytokines
and iNOSmRNA inmicroglia cells in vitro.
In comparison to our recent study on the effect of Ea5
on Raw 264.7 cells, the inhibition of NO production was
89.06% with Raw 264.7 cells (and 87.07% for N9 cells).
Baicalin presented an inhibition of NO production of
63.34% and 70.85% respectively for Raw cells and N9
cells. After treatment with LPS (1 μg/ml) for 24 h, nitrite
concentration in the medium was not significantly dif-
ferent in Raw 264.7 cells (2.011 ± 0.027 μM) and in N9
cells (2.2 ± 0.079 μM). Concerning the inhibition of
proinflammatory cytokines, Ea5 significantly reduced the
mRNA expression of IL-6, TNFα and IL-1β respectively
in Raw 264.7 cells and in N9 cells respectively.
Concerning the inhibition of NO, Ea5 presented the
highest inhibition (87.07%) in comparison with Baicalin
(70.85%). An inhibition of the mRNA expression of IL1-β
and IL-6 was obtained with Ea5 and Baicalin respectively.
Concerning the inhibition of iNOS mRNA expression, a
significant inhibition was obtained with Ea5 (P < 0.01) and
with Baicalin (P < 0.05). These results suggest that Ea5
may have at least the same anti-inflammatory potency as
Baicalin.
E. africana has been reported to be a potent antioxidant
with scavenging activities and to induce hemeoxygenase-1
expression, similar to most antioxidants [16]. The data
presented here suggest that E. africana can strongly
protect host immune cells from inflammation-mediated
cytotoxic conditions induced by cytokine production and
NOgeneration.
Cytokine produced bymicroglia have been shown to be
intimately associatedwith amyloid deposits and have alsobeen implicated as scavengers responsible for clearing
Aβ deposits [26]. Although the molecular mechanism by
which E. africana inhibits the production of NO and pro-
inflammatory cytokines mRNA expression has not been
elucidated, E. africanamaymodulate a common pathway
of microglia response. To date, several important com-
mon pathways have been identified. One of these path-
ways is known to be the nuclear factor NF-kappaB, as it
controls the expression of various protein markers
such as cytokines and surface glycoproteins. Anti-
inflammatory effects of many plant derived compounds
have also been reported to occur via inhibition of the
MAPKs, PI3K/Akt, and Jak/STATpathways [27].
Due to the antioxidant properties of E. africana [16],
we presumed that the suppressive effect of this plant ex-
tract on NO production may be due to its scavenging
properties and the suppression of iNOS at the transcrip-
tional level.
E. africana main constituents are polyphenols [16].
The phenolic compounds present in this plant extract
may be responsible for the observed effects, as many
polyphenols have in many reports been reported as good
anti-inflammatory and immunomodulatory compounds
[28,29]. The results obtained in this study indicate that,
E. africana may also be a good candidate for the treat-
ment of neuropathologies and may act by inhibiting the
over-activation of microglias besides its antioxidant
activity.
However, there are some limitations in the present
study. The study does not evaluate the effect of the ex-
tract on the expression of cytokines, iNOS and NFkB
proteins by western blot. Moreover, many other inhibi-
tors such as COX-2 inhibitors should be used as positive
controls to evaluate the effect of the extract on prosta-
glandins production and COX-2 expression. These limi-
tations will therefore be investigated in our future
studies.
Conclusion
The present study has revealed that E. africana treat-
ment of mouse microglia cells inhibited LPS-induced
NO production by suppressing iNOS mRNA expres-
sion. E. africana also inhibited the production of
pro-inflammatory cytokines, such as TNFα, IL-6 and
IL1-β, by suppressing their transcriptional activity,
the same as did Baicalin, the reference compound
used in this study. This suggests that E. africana
may have substantial therapeutic potential for treat-
ment of neurodegenerative diseases that are accom-
panied by microglia activation. Ongoing studies
concentrate on the isolation and determination of
the pure active compounds present in Ea5 and ex-
plore the signaling pathways responsible for the ob-
served effects.
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